CAD 1.59
(0.63%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -242.73 Million CAD | -526.39% |
2022 | -38.75 Million CAD | 57.8% |
2021 | -91.82 Million CAD | 36.9% |
2020 | -145.51 Million CAD | -2751.9% |
2019 | 5.48 Million CAD | -84.93% |
2018 | 36.41 Million CAD | 426.11% |
2017 | -11.16 Million CAD | -996.47% |
2016 | 1.24 Million CAD | 207.48% |
2015 | -1.15 Million CAD | -1635.72% |
2014 | -66.77 Thousand CAD | 82.21% |
2013 | -375.24 Thousand CAD | -167.72% |
2012 | -140.16 Thousand CAD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -24.37 Million CAD | -53.04% |
2024 Q3 | -18.89 Million CAD | 79.29% |
2024 Q1 | -15.92 Million CAD | 59.53% |
2023 Q2 | -10.84 Million CAD | -367.2% |
2023 Q3 | -219.63 Million CAD | -1925.61% |
2023 Q4 | -39.36 Million CAD | 82.08% |
2023 Q1 | 4.05 Million CAD | 164.46% |
2023 FY | -112.4 Million CAD | -190.06% |
2022 Q4 | -6.29 Million CAD | 46.58% |
2022 Q3 | -11.78 Million CAD | -69.55% |
2022 Q2 | -6.95 Million CAD | 49.36% |
2022 FY | -38.75 Million CAD | 57.8% |
2022 Q1 | -13.72 Million CAD | 37.96% |
2021 Q2 | -29.27 Million CAD | -3.75% |
2021 Q3 | -12.21 Million CAD | 58.27% |
2021 Q4 | -22.12 Million CAD | -81.09% |
2021 Q1 | -28.21 Million CAD | 33.35% |
2021 FY | -91.82 Million CAD | 36.9% |
2020 Q3 | -99.3 Million CAD | -2366.69% |
2020 Q4 | -42.32 Million CAD | 57.38% |
2020 FY | -145.51 Million CAD | -2751.9% |
2020 Q1 | 154 Thousand CAD | 100.56% |
2020 Q2 | -4.02 Million CAD | -2714.29% |
2019 Q4 | -27.7 Million CAD | -145.42% |
2019 Q1 | 46.24 Million CAD | 58.69% |
2019 Q3 | -11.28 Million CAD | -538.46% |
2019 FY | 5.48 Million CAD | -84.93% |
2019 Q2 | -1.76 Million CAD | -103.82% |
2018 Q3 | 6.49 Million CAD | 192.69% |
2018 FY | 36.41 Million CAD | 426.11% |
2018 Q4 | 29.14 Million CAD | 348.41% |
2018 Q2 | 2.22 Million CAD | 253.61% |
2018 Q1 | -1.44 Million CAD | 31.16% |
2017 Q1 | -719 Thousand CAD | -202.17% |
2017 Q2 | -5.88 Million CAD | -718.88% |
2017 Q3 | -2.46 Million CAD | 58.22% |
2017 Q4 | -2.09 Million CAD | 14.64% |
2017 FY | -11.16 Million CAD | -996.47% |
2016 Q3 | 491.97 Thousand CAD | 182.3% |
2016 Q4 | 703.73 Thousand CAD | 43.04% |
2016 FY | 1.24 Million CAD | 207.48% |
2016 Q1 | -124.35 Thousand CAD | -217.76% |
2016 Q2 | 174.27 Thousand CAD | 240.14% |
2015 Q2 | -606.36 Thousand CAD | 25.92% |
2015 Q1 | -818.53 Thousand CAD | -340.38% |
2015 Q4 | 105.59 Thousand CAD | -33.11% |
2015 FY | -1.15 Million CAD | -1635.72% |
2015 Q3 | 157.85 Thousand CAD | 126.03% |
2014 Q4 | -185.87 Thousand CAD | -638.03% |
2014 Q2 | -15.69 Thousand CAD | -18.71% |
2014 Q1 | -13.22 Thousand CAD | -4.32% |
2014 FY | -66.77 Thousand CAD | 82.21% |
2014 Q3 | -25.18 Thousand CAD | -60.49% |
2013 Q2 | -58.7 Thousand CAD | 76.78% |
2013 Q1 | -252.8 Thousand CAD | -315.97% |
2013 Q3 | -2962.00 CAD | 94.95% |
2013 Q4 | -12.67 Thousand CAD | -327.85% |
2013 FY | -375.24 Thousand CAD | -167.72% |
2012 FY | -140.16 Thousand CAD | 0.0% |
2012 Q3 | -43.44 Thousand CAD | 46.39% |
2012 Q2 | -81.03 Thousand CAD | -1168.18% |
2012 Q1 | -6390.00 CAD | 31.26% |
2012 Q4 | -60.77 Thousand CAD | -39.9% |
2011 Q2 | - CAD | 0.0% |
2011 Q1 | - CAD | 0.0% |
2011 Q4 | -9296.00 CAD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Aurora Cannabis Inc. | -46.45 Million CAD | -422.547% |
Avicanna Inc. | -7.93 Million CAD | -2959.858% |
Avant Brands Inc. | -1.45 Million CAD | -16629.069% |
Cardiol Therapeutics Inc. | -29.78 Million CAD | -714.956% |
Crescita Therapeutics Inc. | -1.95 Million CAD | -12309.959% |
Knight Therapeutics Inc. | -2.89 Million CAD | -8299.266% |
MediPharm Labs Corp. | -18.25 Million CAD | -1229.93% |
Canopy Growth Corporation | -228.71 Million CAD | -6.132% |
Willow Biosciences Inc. | -13.18 Million CAD | -1741.441% |
Auxly Cannabis Group Inc. | -19 Million CAD | -1177.236% |